e-learning
resources
Copenhagen 2005
Monday 19.09.2005
COPD - treatment III
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD and asthma: the effect of glucocorticosteroid therapy on tolerance to physical activity
A. A. Denisenko, O. V. Dudina, V. I. Trofimov (St. Petersburg, Russian Federation)
Source:
Annual Congress 2005 - COPD - treatment III
Session:
COPD - treatment III
Session type:
Thematic Poster Session
Number:
1962
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. A. Denisenko, O. V. Dudina, V. I. Trofimov (St. Petersburg, Russian Federation). COPD and asthma: the effect of glucocorticosteroid therapy on tolerance to physical activity. Eur Respir J 2005; 26: Suppl. 49, 1962
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Bronchodiator therapy in COPD: physiological effects
Source: Breathe 2008; 4: 342-344
Year: 2008
Omalizumab improves asthma control in patients receiving high-dose ICS and multiple other controller therapies and who have continuing impairment of lung function and asthma symptoms
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007
Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 261s
Year: 2001
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Addition of theophylline to standard inhalatory therapy in patients with stable COPD: effects on exercise tolerance
Source: Eur Respir J 2006; 28: Suppl. 50, 215s
Year: 2006
The effect of high dose bronchodilators on cardiac function in elderly people with severe COPD or asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002
The effect on mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A focus on the frequent exacerbator phenotype
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
The effects of adding in erdosteine on the routine bronchodilator therapy in moderate and severe COPD patients
Source: Annual Congress 2006 - COPD therapy
Year: 2006
Pulmonary function test changes after cessation of inhaled corticosteroid therapy in asthma patients
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012
The effects of physical activity coaching in patients with COPD after an acute exacerbation
Source: International Congress 2014 – Exercise training and physical activity in patients with COPD
Year: 2014
Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function
Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Year: 2020
Evaluating the effects of inhaled corticosteroid on insulin sensitivity in asthmatic patients
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Influence of combined antiasthmatic basic therapy on hyperinflation in patients with severe bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 553s
Year: 2007
Effects of a single inhaled budesonide/formoterol dose on glucocorticoid receptor activity in sputum of COPD patients
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016
The effect of different bronchodilator drugs on pulmonary function tests, exercise capacity and quality of life in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 515s
Year: 2005
Effect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma
Source: Eur Respir J 2001; 17: 374-379
Year: 2001
Smoking, sputum cell counts, diffusion capacity and hyperinflation predict beneficial effects of long-term inhaled corticosteroids (ICS) on FEV1-decline in patients with mild-to-moderate COPD
Source: Annual Congress 2010 - COPD: management
Year: 2010
Physical activity and the use of COPD medication
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015
The effects of physical activity on asthma incidence
Source: Annual Congress 2009 - Epidemiology of atopy and asthma
Year: 2009
Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept